| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-07 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-06 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
9e-05 |